Shares of CSL Limited Sponsored ADR (CSLLY) have been struggling lately and have lost 14.2% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...

ADRs of CSL Limited (OTCQX:CSLLY) dropped ~16% on Tuesday as Wall Street reacted to Australian biotech’s plans to lay off 15% of its workforce, announced in conjunction with its fiscal 2025 financials ...

Fintel reports that on December 8, 2025, JEFFERIES maintained coverage of CSL Limited - Depositary Receipt (OTCPK:CSLLY) with a Buy recommendation. As of December 6, 2025, the average one-year price ...

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both CSL Limited Sponsored ADR (CSLLY) and argenex SE (ARGX). But which of these two companies is the ...

CSL ( (AU:CSL)) has issued an announcement. CSL Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back program for its ordinary fully paid shares. The ...

Brokers see significantly more upside ahead for Pro Medicus. The post Forget CSL shares, this ASX healthcare stock could double in value appeared first on The Motley Fool Australia.

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either CSL Limited Sponsored ADR (CSLLY) or argenex SE (ARGX). But which of these two stocks is more ...

CSL ( (AU:CSL)) has issued an update. CSL Limited has provided an updated notification to the ASX on its ongoing on-market share buy-back of ordinary fully paid shares, originally launched in August ...